Application of Molecular Hydrogen in Heart Surgery under Cardiopulmonary Bypass

The aim of this work was to study the effect of molecular hydrogen on oxidative processes in cardiac surgery patients with acquired valve heart disease applied during surgery under cardiopulmonary bypass (CPB).

Materials and Methods. The study involved 20 patients (16 men and 4 women) with acquired heart valve disease who were operated on under CPB. Two groups of patients were formed. In group 1 (n=11), anesthesia included inhalations of molecular hydrogen, which was supplied to the breathing circuit of the ventilator at a concentration of 1.5–2.0% immediately after tracheal intubation and throughout the operation. In group 2 (n=9), inhalation of molecular hydrogen was not performed. Blood sampling was taken at 4 stages: immediately after anesthesia induction, before CPB and after its termination, and also one day after the operation. The intensity of the processes of lipid peroxidation was evaluated by the level of diene (DC) and triene (TC) conjugates, Schiff bases (SB).

Results. In the patients of group 1, the arterial blood samples showed a decrease in the level of TC and SB, as compared to the first stage of the study, before the initiation of CPB and one day after the operation. An increase in the level of DC and TC was detected after the termination of CPB (p<0.05). In the venous blood samples, an increase in the level of DC was noted before the initiation of CPB, which was restored by the third stage of the study (p<0.05). At the same time, after the termination of CPB, a tendency towards a decrease in TC and SB was observed, which persisted one day after the operation.

In the patients of group 2, an increase in the concentration of SB in the arterial blood samples was recorded during the study as compared to the first stage. The level of TC and SB in the venous blood samples increased one day after the operation.

Conclusion. Intraoperative inhalation of molecular hydrogen leads to a decrease in the oxidative stress manifestation, it being most pronounced one day after the operation. This suggests that molecular hydrogen can be used in cardiac surgery as an effective and safe antioxidant.

1. Shlyahto E.V. Kardiologiya: natsional’noe rukovodstvo [Cardiology: a national guide]. Moscow: GEOTAR-Media; 2015; 800 p.
2. Urazova G.E., Landyshev Yu.S., Vakhnenko Yu.V., Pogrebnaya M.V., Vymenkhin A.N. Priobretennye poroki serdtsa. Diagnostika i lechenie [Acquired heart defects. Diagnostics and treatment]. Blagoveshchensk; 2010; 153 p.
3. Artykova T.K., Ismailov K.I. Lipid peroxidation and antioxidant protection in children with vegetative-vascular dystonia. Vestnik Avitsenny 2015; 3: 117–120.
4. Lankin V.Z., Tikhaze A.K., Belenkov Yu.N. Free radical processes in diseases of the cardiovascular system. Kardiologia 2000; 40(7): 48–61.
5. Okunevich I.V., Sapronov N.S. Antioxidants: the effectiveness of natural and synthetic compounds in the complex therapy of cardiovascular diseases. Obzory po kliniсeskoj farmakologii i lekarstvennoj terapii 2004; 3(3): 2–17.
6. Li J., Wang C., Zhang J., Cai J.M., Cao Y.P., Sun X.J. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress. Brain Res 2010; 1328: 152–1561, https://doi.org/10.1016/j.brainres.2010.02.046.
7. Xie K., Yu Y., Zhang Z., Liu W., Pei Yu., Xiong L., Hou L., Wang G. Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock 2010; 34(5): 495–501, https://doi.org/10.1097/shk.0b013e3181def9aa.
8. Yang Y., Li B., Liu C., Chuai Yu., Lei J., Gao F., Cui J., Sun D., Cheng Y., Zhou C., Cai J. Hydrogen-rich saline protects immunocytes from radiation-induced apoptosis. Med Sci Monit 2012; 18(4): BR144–148, https://doi.org/10.12659/msm.882616.
9. Song G., Li M., Sang H., Zhang L., Li X., Yao S., Yu Y., Zong C., Xue Y., Qin S. Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome. J Lipid Res 2013; 54(7): 1884–1893, https://doi.org/10.1194/jlr.m036640.
10. Hong Y., Chen S., Zhang J.M. Hydrogen as a selective antioxidant: a review of clinical and experimental studies. J Int Med Res 2010; 38(6): 1893–1903, https://doi.org/10.1177/147323001003800602.
11. Dixon B.J., Tang J., Zhang J.H. The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance. Med Gas Res 2013; 3(1): 10, https://doi.org/10.1186/2045-9912-3-10.
12. Tarasov N.I., Teplyakov A.T., Malakhovich E.V., Stepacheva T.A., Kalyuzhin V.V., Pushnikova E.Yu., Fedosova N.N. The state of lipid peroxidation, antioxidant protection of blood in patients with myocardial infarction, aggravated by circulatory insufficiency. Terapevticheskii arkhiv 2002; 12: 12–15.
13. Boyarinov G.A., Boyarinova L.V., Deryugina A.V., Solov’eva O.D., Zaytsev R.R., Voyennov O.V., Moshnina E.V., Shumilova A.V. Role of secondary brain damage factors in activation of vascularplatelet hemostasis in traumatic brain injury. Obsaa reanimatologia 2016; 12(5): 42–51, https://doi.org/10.15360/1813-9779-2016-5-42-51.
14. Ge L., Yang M., Yang N.N., Yin X.X., Song W.G. Molecular hydrogen: a preventive and therapeutic medical gas for various diseases. Oncotarget 2017; 8(60): 102653–102673, https://doi.org/10.18632/oncotarget.21130.
15. Deryugina A.V., Boyarinov G.A., Simutis I.S., Nikolskiy V.O., Kuznetsov A.B., Efimova T.S. Сorrection of metabolic indicators of erythrocytes and the structure of myocardium after acute blood loss using an ozonized erythrocytal mass. Tsitologiya 2018; 60(2): 89–95, https://doi.org/10.31116/tsitol.2018.02.03.
16. Ohta S. Molecular hydrogen as preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol Ther 2014; 144(1): 1–11, https://doi.org/10.1016/j.pharmthera.2014.04.006.
17. Boyarinov G.A., Simutis I.S., Nikolsky V.O., Deryugina A.V., Boyarinova L.V., Gordetsov A.S., Kuznetsov A.B. The role of ozonized erythrocytic mass transfusion in the restoration of myocardial morphological changes during blood loss (experimental study). Obsaa reanimatologia 2018; 14(3): 27–35, https://doi.org/10.15360/1813-9779-2018-3-27-35.
18. Ohsawa I., Ishikawa M., Takahashi K., Watanabe M., Nishimaki K., Yamagata K., Katsura K., Katayama Y., Asoh S., Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007; 13(6): 688–694, https://doi.org/10.1038/nm1577.
19. Chepur S.V., Pluzhnikov N.N., Khurtsilava O.G., Maevsky E.I., Gogolevsky A.S., Tyunin M.A., Bakulina L.S., Lobeeva A.S. Biological effects of molecular hydrogen and its application in clinical practice. Uspehi sovremennoj biologii 2017; 137(3): 311–318.
20. Li H.М., Shen L., Ge J.W., Zhang R.F. The transfer of hydrogen from inert gas to therapeutic gas. Med Gas Res 2017; 7(4): 265–272, https://doi.org/10.4103/2045-9912.222451.

Danilova D.A., Brichkin Yu.D., Medvedev A.P., Pichugin V.V., Fedorov S.A., Taranov E.V., Nazarov E.I., Ryazanov M.V., Bolshukhin G.V., Deryugina A.V. Application of Molecular Hydrogen in Heart Surgery under Cardiopulmonary Bypass. Sovremennye tehnologii v medicine 2021; 13(1): 71, https://doi.org/10.17691/stm2021.13.1.09